Kaissar Tabynov

6PUBLICATIONS
11CO-AUTHORS
AllergySpeciation and extinctionAgricultural molecular engineering of nucleic acids and proteinsNanomedicineBiomaterials
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 07, 2026
Adjuvant Strategies to Improve the Efficacy of Allergen Immunotherapy.

|Jul 22, 2024
Detection and genomic characterization of an avian influenza virus A/mute swan/Mangystau/1-S24R-2/2024 (H5N1; clade 2.3.4.4b) strain isolated from the lung of a dead swan in Kazakhstan.

Kairat Tabynov, Vitaliy Strochkov, Nurlan Sandybayev

|Oct 26, 2023
Evaluation of a SARS-CoV-2 spike protein ectodomain subunit vaccine with a squalene emulsion adjuvant in rodents and rhesus macaques.

Maxim Solomadin, Kairat Tabynov, Nikolai Petrovsky

|Feb 24, 2022
An adjuvanted subunit SARS-CoV-2 spike protein vaccine provides protection against Covid-19 infection and transmission.

Kairat Tabynov, Nurkeldi Turebekov, Meruert Babayeva

|Dec 04, 2020
Development of Human Vectored Brucellosis Vaccine Formulation: Assessment of Safety and Protectiveness of Influenza Viral Vectors Expressing Brucella Immunodominant Proteins in Mice and Guinea Pigs.

Dina Bugybayeva, Sholpan Ryskeldinova, Nadezhda Zinina

|Oct 13, 2017
Improved influenza viral vector based Brucella abortus vaccine induces robust B and T-cell responses and protection against Brucella melitensis infection in pregnant sheep and goats.

Aigerim Mailybayeva, Bolat Yespembetov, Sholpan Ryskeldinova

Pageof 1

Frequent Collaborators

2 joint publications

Nikolai Petrovsky

1 joint publications

Dina Bugybayeva

1 joint publications

Sholpan Ryskeldinova

1 joint publications

Nadezhda Zinina